Protein-Encoding Chemically Modified mRNAs for Musculoskeletal Tissue Regeneration and Repair
Journal of Functional Biomaterials · 01.04.2026 · 17 (4) · 167
DOI: 10.3390/jfb17040167 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 01.04.2026. Verfasst von Britney S Force und 2 weiteren Autor:innen. Beteiligte Einrichtung: Linda and Mitch Hart Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO 81657, USA. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Steadman Philippon Research Institute.
Abstract (Originalsprache)
Musculoskeletal disorders and injuries are highly prevalent and encompass a broad range of conditions, including bone fractures and segmental defects, tendinopathies and tendon injury, and cartilage disorders such as osteoarthritis, cartilage defects, and intervertebral disc disease. These conditions can arise from diverse causes including trauma and injury, tumor resection, congenital abnormalities, and age-related degeneration. In the past decades, administration of chemically modified mRNA (cmRNA) encoding growth factors and transcriptional regulators has demonstrated effectiveness in repairing musculoskeletal tissues in preclinical studies. This review summarizes recent advancements in bone, tendon, cartilage, intervertebral disc, and muscle regeneration achieved through the localized delivery of protein-encoding mRNAs to express therapeutic target proteins. Delivery of cmRNA encoding growth factors such as BMP-2, BMP-9, VEGF, FGF-18, and IGF-1, or transcriptional regulators including Runx1, to various animal models has shown beneficial effects on bone, tendon, cartilage, and muscle injury repair in preclinical models. Alongside these progresses, the advantages and disadvantages of applying chemically modified mRNA for musculoskeletal tissue regeneration are also discussed. While studies show the promise of cmRNA for therapeutic applications in orthopedic tissue regeneration, more research is required to optimize growth factors and delivery methods, as well as validate long-term safety and efficacy prior to successful translation into new therapies to benefit patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Linda and Mitch Hart Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO 81657, USA.
ORCID-Profile: Xueqin Gao
Förderung
- Steadman Philippon Research Institute
Zitieren
APA
Force, B. S., Gao, X., & Huard, J. (2026). Protein-Encoding Chemically Modified mRNAs for Musculoskeletal Tissue Regeneration and Repair. Journal of Functional Biomaterials, 17(4), 167. https://doi.org/10.3390/jfb17040167
Vancouver
Force BS, Gao X, Huard J. Protein-Encoding Chemically Modified mRNAs for Musculoskeletal Tissue Regeneration and Repair. Journal of Functional Biomaterials. 2026;17(4):167. doi:10.3390/jfb17040167
BibTeX
@article{Force2026,
author = {Force, Britney S and Gao, Xueqin and Huard, Johnny},
title = {Protein-Encoding Chemically Modified mRNAs for Musculoskeletal Tissue Regeneration and Repair},
journal = {Journal of Functional Biomaterials},
year = {2026},
volume = {17},
number = {4},
pages = {167},
doi = {10.3390/jfb17040167}
}
EUVIMED